Del Monte
Del Monte's revenue rose 1.0% to $4.3 billion in fiscal 2025. Its operating margin was 3.2%, down from 4.6% a year earlier. Free cash flow was $181 million, up 38.6%. It paid out $87 million in dividends and buybacks, 48% of free cash flow. The diluted share count rose 0.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 8.9% a year and net income 9.6% a year, while buybacks cut the share count by 7%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Del Monte yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Del Monte's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Del Monte's fiscal 2025 free cash flow of $181M, net cash of −$142M at December 26, 2025 and 48 million diluted shares, from its filings. The scenarios are fitted to Del Monte: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -0.9% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9%: 7% for a stable business (Packaged Foods & Meats), plus 1 point as a smaller company, worth $1.4B, plus 1 point for unsteady results (a loss in fiscal 2023); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $29.10
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Del Monte's earnings per share of $0.70 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26×, the middle of Del Monte's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $29.10
- Value at this multiple, against the last close
- —
- Del Monte's P/E at the last close
- 41.6×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Cal-Maine FoodsCALM | $62.32 | $1.22 | 51.1× |
| Del MonteDMC | $29.10 | $0.70 | 41.6× |
| Lamb WestonLW | $53.67 | $1.83 | 29.3× |
| Flowers FoodsFLO | $6.14 | $0.27 | 22.7× |
| McCormickMKC | $47.97 | $5.53 | 8.7× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 16 | 17 | 34 | 33 | 36 |
| Debt incl. finance leases | 529 | 548 | 408 | 250 | 178 |
| Net debt (negative means net cash) | 513 | 531 | 374 | 218 | 142 |
| Net debt to EBITDA | 2.5x | 2.1x | 2.6x | 0.8x | 0.7x |
| Debt to equity | 0.3x | 0.3x | 0.2x | 0.1x | 0.1x |
| Interest coverage | 5.5x | 6.4x | 2.4x | 10.7x | 12.3x |
| Current ratio | 1.7x | 2.0x | 2.1x | 2.1x | 2.2x |
| Quick ratio | 0.8x | 0.9x | 1.0x | 1.0x | 1.1x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $476,320 of Del Monte shares on the open market, and 10 insiders sold $3.2 million, $1.1 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Danny DumasSVP, NA Sales, Mkt & Prd Mgmt | Sold | 245 | $32.03 | $7,847 | Form 4 |
| Aug 4, 2026 | Mohammed AbbasPresident & COO | Bought | 12,000 | $29.89 | $358,680 | Form 4 |
| Jun 11, 2026 | Ahmad Abu-GhazalehDirector | Bought | 4,000 | $29.41 | $117,640 | Form 4 |
| May 28, 2026 | Reyes Jorge PelaezSVP, Central America | Sold | 2,622 | $33.19 | $87,024 | Form 4 |
| Apr 2, 2026 | Marissa R TenazasSVP, CHRO | Sold | 1,046 | $40.40 | $42,258 | Form 4 |
| Mar 9, 2026 | Effie D SilvaSVP, General Counsel & Secy | Sold | 5,894 | $41.94 | $247,194 | Form 4 |
| Mar 6, 2026 | Ziad NabulsiSVP, North American Operations | Sold | 7,395 | $42.01 | $310,664 | Form 4 |
| Mar 6, 2026 | Gianpaolo ReninoSVP Europe & Africa | Sold | 6,297 | $41.46 | $261,074 | Form 4 |
| Mar 4, 2026 | Mohammed AbbasPresident & COO | Sold | 3,458 | $42.28 | $146,204 | Form 4 |
| Mar 4, 2026 | Marissa R TenazasSVP, CHRO | Sold | 1,969 | $42.28 | $83,249 | Form 4 |
| Mar 4, 2026 | Monica VicenteSVP, Chief Financial Officer | Sold | 1,260 | $42.28 | $53,273 | Form 4 |
| Mar 4, 2026 | Effie D SilvaSVP, General Counsel & Secy | Sold | 1,072 | $42.28 | $45,324 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 8 of 9 | 7 of 9 |
| Accruals ratio | −5.7% | −1.3% | −5.0% |
Compare
Put Del Monte side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Del Monte | FY25 | 1.0% | 3.2% | 4.2% | 4.5% | 0.7x | 7 | |
| Flowers Foods | FY25 | 3.0% | 3.3% | 6.1% | 4.6% | 5.1x | 5 | Compare |
| Cal-Maine Foods | FY26 | −31.7% | 12.0% | 11.3% | — | — | — | Compare |
| Lamb Weston | FY26 | 2.5% | 8.9% | 8.2% | 7.1% | 3.9x | 7 | Compare |
| McCormick | FY25 | 1.7% | 15.7% | 10.8% | 8.7% | 3.1x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 4,012 | 4,086 | 4,494 | 4,489 | 4,202 | 4,252 | 4,442 | 4,321 | 4,280 | 4,322 |
| Revenue growth | −1.1% | 1.9% | 10.0% | −0.1% | −6.4% | 1.2% | 4.5% | −2.7% | −0.9% | 1.0% |
| Gross profit | 461 | 332 | 286 | 306 | 251 | 304 | 340 | 351 | 358 | 399 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 244 | 153 | 39 | 114 | 76 | 111 | 156 | 58 | 196 | 137 |
| Net income | 225 | 121 | −22 | 66 | 49 | 80 | 99 | −11 | 142 | 91 |
| Diluted EPS (US$) | 4.33 | 2.39 | −0.45 | 1.37 | 1.03 | 1.68 | 2.06 | −0.24 | 2.96 | 1.88 |
| Diluted shares (millions) | 52 | 51 | 49 | 48 | 48 | 48 | 48 | 48 | 48 | 48 |
| Cash flow | ||||||||||
| Cash from operations | 345 | 194 | 247 | 169 | 181 | 128 | 62 | 178 | 182 | 245 |
| Capital expenditure | 147 | 138 | 150 | 122 | 150 | 98 | 48 | 58 | 52 | 64 |
| Free cash flow | 198 | 56 | 96 | 47 | 31 | 30 | 14 | 120 | 131 | 181 |
| Dividends paid | 28 | 30 | 29 | 7 | 14 | 24 | 29 | 36 | 48 | 57 |
| Share buybacks | 108 | 142 | 29 | 18 | 21 | 0 | 0 | 12 | 0 | 30 |
| Acquisitions | 9 | 0 | 358 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 25 | 12 | 12 | 8 | 8 | 8 | 7 | 10 | 7 | 10 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 20 | 25 | 21 | 33 | 16 | 16 | 17 | 34 | 33 | 36 |
| Debt incl. finance leases | 269 | 396 | 725 | 587 | 542 | 529 | 548 | 408 | 250 | 178 |
| Total assets | 2,653 | 2,767 | 3,255 | 3,350 | 3,263 | 3,398 | 3,459 | 3,184 | 3,096 | 3,059 |
| Total liabilities | 837 | 976 | 1,486 | 1,551 | 1,463 | 1,525 | 1,484 | 1,271 | 1,089 | 1,029 |
| Shareholders' equity | 1,792 | 1,767 | 1,692 | 1,719 | 1,728 | 1,802 | 1,905 | 1,896 | 1,990 | 2,016 |
| Margins and ratios | ||||||||||
| Gross margin | 11.5% | 8.1% | 6.4% | 6.8% | 6.0% | 7.1% | 7.7% | 8.1% | 8.4% | 9.2% |
| Operating margin | 6.1% | 3.7% | 0.9% | 2.5% | 1.8% | 2.6% | 3.5% | 1.4% | 4.6% | 3.2% |
| Net margin | 5.6% | 3.0% | −0.5% | 1.5% | 1.2% | 1.9% | 2.2% | −0.3% | 3.3% | 2.1% |
| Free cash flow margin | 4.9% | 1.4% | 2.1% | 1.0% | 0.7% | 0.7% | 0.3% | 2.8% | 3.1% | 4.2% |
| Return on capital | 11.3% | 6.0% | 0.8% | 3.7% | 3.0% | 4.7% | 5.4% | 1.2% | 7.2% | 4.5% |
| Return on equity | 12.9% | 6.8% | −1.3% | 3.9% | 2.9% | 4.5% | 5.3% | −0.6% | 7.3% | 4.5% |
| Return on assets | 8.6% | 4.5% | −0.7% | 2.0% | 1.5% | 2.4% | 2.9% | −0.3% | 4.5% | 3.0% |
| Net debt to EBITDA | 0.8x | 1.6x | 5.1x | 2.6x | 3.1x | 2.5x | 2.1x | 2.6x | 0.8x | 0.7x |